Article de revue
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study
Bivalent oral poliovirus vaccine (bOPV; types 1 and 3) is expected to replace trivalent OPV (tOPV) globally by April, 2016, preceded by the introduction of at least one dose of inactivated poliovirus vaccine (IPV) in routine immunisation programmes to eliminate vaccine-associated or vaccine-derived poliomyelitis from serotype 2 poliovirus. Because data are needed on sequential IPV–bOPV schedules, the researchers assessed the immunogenicity of two different IPV–bOPV schedules compared with an all-IPV schedule in infants.
Auteurs
Langues
- Anglais
Année de publication
2015
Journal
The Lancet Infectious Diseases
Volume
11
Type
Article de revue
Catégories
- Prestation de services
Maladies
- Polio
Pays
- Chili
Mots-clés
- IPV
- OPV
Régions de l'OMS
- Région des Amériques